About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 761 record(s)
Req # A-2023-001382
Obtain certain information regarding the state of company records held by your organization. Company: Groupe BFL Inc. (NEQ: 1169110567) 2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Technologies Échangeurs Gaz-Air (TEGA) Inc. (NEQ: 1148440044) 2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Innovation Nagas Inc. (also: Nagas Innovation Inc.) (NEQ: 1166256652) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Bousquet Technologies Inc. (NEQ: 1142014423) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Bousquet Frères Ltd. (NEQ: 1163420616) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9.Organization: Health Canada
February 2024
Req # A-2023-001385
All communications to/from Health Canada (HC), Public Health Agency Of Canada (PHAC) and National Advisory Committee on Immunization (NACI) or any subcommittee, agency, ad hoc group, project team regarding correspondence from Dr. Theresa (“Tess”) Lawrie or Tess Lawrie about ivermectin in the period of 2020-2023.Organization: Health Canada
February 2024
Req # A-2024-00011
The total amount money spent on training NCC employees in “Gender-based Analysis Plus.”Organization: National Capital Commission
February 2024
Req # A-2024-00012
The total amount of money that was spent on developing the NCC’s updated Gender-based Analysis Plus guidelines.Organization: National Capital Commission
February 2024
Req # A-2024-00015
Records showing how much was spent constructing gender-neutral washrooms as part of the NCC’s Westboro Beach Area Development.Organization: National Capital Commission
February 2024
Req # A-2024-00030
All correspondence with officials at Enbridge or its subsidiary Gazifère concerning Winterlude. Limit Feb. 1, 2023 to Feb. 1, 2024, exclude drafts.Organization: National Capital Commission
February 2024
Req # A-2023-000594
All notes made by the Health Canada employees who reviewed the AstraZeneca Vaxzevria COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.Organization: Health Canada
January 2024
Req # A-2023-000601
All notes made by the Health Canada employees who reviewed the Janssen Jcovden (Johnson & Johnson) COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.Organization: Health Canada
January 2024
Req # A-2023-001171
Information about whether or not Canada donates or sends blood to foreign countries and if yes to which countries did Canada send blood during the years from 2019 until present time.Organization: Health Canada
January 2024
Req # A-2023-001214
Correspondence relating to any abbreviated new drug submission (ANDS) filed since July 1, 2023 where the medicinal ingredient is liraglutide alone and the indication includes chronic weight management.Organization: Health Canada
January 2024